Results
Par Drugs Q1 FY27 Net Profit Rises 42% YoY
Par Drugs reported unaudited standalone Q1 FY27 revenue of ₹3,128.05 lakh and net profit of ₹471.27 lakh, showing significant YoY growth.
The Board approved availing forward booking facilities from IC
